Beneficial action of candesartan cilexetil plus amlodipine or ACE inhibitors in chronic nondiabetic renal disease (Q45007835)

8 December 2017

title

Beneficial action of candesartan cilexetil plus amlodipine or ACE inhibitors in chronic nondiabetic renal disease (English)

1 reference

8 December 2017

K Homma

1

1 reference

8 December 2017

K Hayashi

2

1 reference

8 December 2017

T Kanda

3

1 reference

8 December 2017

K Yoshioka

4

1 reference

8 December 2017

I Takamatsu

5

1 reference

8 December 2017

S Tatematsu

6

1 reference

8 December 2017

H Kumagai

7

1 reference

8 December 2017

S Wakino

8

1 reference

8 December 2017

T Saruta

9

1 reference

8 December 2017

publication date

1 December 2004

1 reference

Journal of Human Hypertension

8 December 2017

published in

1 reference

8 December 2017

volume

18

1 reference

8 December 2017

issue

12

1 reference

8 December 2017

page(s)

879-884

1 reference

The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001761

The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001761

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001761

Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001761

Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001761

Distinct time courses of renal protective action of angiotensin receptor antagonists and ACE inhibitors in chronic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001761

The effects of an ACE inhibitor and a calcium antagonist on the progression of renal disease: the Nephros Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001761

Calcium channel blocker azelnidipine enhances vascular protective effects of AT1 receptor blocker olmesartan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001761

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001761

Antiproteinuric effects of combined antihypertensive therapies in patients with overt type 2 diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001761

RISE IN PLASMA CONCENTRATION OF ALDOSTERONE DURING LONG-TERM ANGIOTENSIN II SUPPRESSION

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001761

Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001761

7 January 2021

Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001761

7 January 2021

Possible mechanism for the renoprotective effect of angiotensin converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001761

7 January 2021

Blood pressure and end-stage renal disease in men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001761

7 January 2021

Disparate effects of calcium antagonists on renal microcirculation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001761

7 January 2021

Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001761

7 January 2021

Identifiers

DOI

10.1038/SJ.JHH.1001761

1 reference

Dimensions Publication ID

8 December 2017

1038213351

0 references

1 reference